September 9, 2009 – CardiacAssist Inc. said yesterday it will exhibit its TandemHeart System in San Francisco at the TCT 2009 and will highlight speakers who have used the device in their cath labs.

September 8, 2009 – Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, said last week it received $36 million in financing to fund the European commercialization and U.S. premarket approval (PMA) clinical study of the company’s TactiCath force-sensing ablation catheter.

September 8, 2009 – Actelion Pharmaceuticals U.S. Inc. recently announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis, for the treatment of New York Heart Association Class III and IV pulmonary arterial hypertension (PAH).

September 8, 2009 – Siemens Healthcare and SurgiVision Inc. today announced an agreement for the codevelopment and commercialization of a real-time magnetic resonance image (MRI)-guided cardiac electrophysiology (EP) system.

The HI-TORQUE Balance Middle Weight (BMW) Universal II Guide Wire offers the same performance of Abbott’s HT BMW UNIVERSAL wire, but includes the two advanced coating technologies and better coating durability for longer procedures

The Perclose ProGlide 6 Fr. Suture-Mediated Closure System delivers a secure, reliable vessel closure to provide complete tissue apposition resulting in primary healing, reduces time to hemostasis, ambulation and discharge, and does not have any reaccess restrictions.

September 3, 2009 – Percutaneous cardiac valve maker Evalve Inc. announced treatment this week of the first group of patients with the MitraClip system at the Karolinska University Hospital in Solna, Stockholm, Sweden.

September 3, 2009 – Important new findings in patients with angina participating in the BEAUTIFUL study show that there is a 42 percent reduction in heart attack with Procoralan (ivabradine), as presented today at the European Society of Cardiology (ESC) Congress.

September 3, 2009 – ZOLL Medical Corp. received approval from the FDA to market and sell a new model of the LifeVest wearable defibrillator.

The HI-TORQUE Versacore .035 Guide Wire is a peripheral guide wire is designed for routine diagnostic and device delivery for balloons and stents in peripheral vessels. Versacore features a soft, shapeable tip to provide safe access to peripheral lesions and enhanced visibility under fluoroscopy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now